Section Arrow
DERM.NASDAQ
- Journey Medical Corp
Quotes are at least 15-min delayed:2026/05/13 07:50 EDT
Pre Market
Last
 5.06
+0.05 (+1.00%)
Bid
5
Ask
5.35
High 5.06 
Low 5.06 
Volume 1.38K 
Regular Hours (Closed)
Last
 5.01
+0.01 (+0.20%)
Day High 
5.095 
Prev. Close
1-M High
5.6 
Volume 
364.79K 
Bid
5
Ask
5.35
Day Low
4.83 
Open
4.93 
1-M Low
4.84 
Market Cap 
136.73M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.12 
20-SMA 5.15 
50-SMA 5.94 
52-W High 9.555 
52-W Low 4.31 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.47/0.81
Enterprise Value
162.03M
Balance Sheet
Book Value Per Share
1.16
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
61.86M
Operating Revenue Per Share
2.25
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health25.03-4.11-14.10%57.14PE
Pre Market 24.84 -0.19 -0.76%
ZTSZOETIS76.94+0.27+0.35%12.61PE
Pre Market 77.25 +0.31 +0.40%
CPHIChina Pharma Holdings Inc0.8927+0.35855+67.13%-- 
Pre Market 0.859 -0.0337 -3.78%
VTRSViatris17.17+0.25+1.48%-- 
Pre Market 17.17 0 0.00%
ELANElanco Animal Health21.43-0.29-1.34%-- 
Pre Market 21.75 +0.32 +1.49%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.